A hallmark of human type 2 diabetes is hyperglycaemia — an excess of glucose in the bloodstream. Normally, the pancreatic β-cell compensate for this by secreting more insulin, but this fail-safe mechanism seems to malfunction in patients with the condition. Now, by generating mice that lack the insulin-receptor substrate-2 (IRS-2) gene, one group has shown that IRS-2 may be responsible for both increased insulin resistance and reduced insulin compenation. The knockout mice develop a syndrome that closely resembles human type 2 diabetes and, importantly, they have fewer β-cells than wild-type mice.